Vanguard Group Inc Vaccinex, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.44 - $131.17 $305 - $91,031	694 Added 0.09%	732,859 $469,000
Q3 2022 Nov 14, 2022	BUY	$0.48 - $109.22 $2,352 - $535,178	4,900 Added 0.67%	732,165 $363,000
Q1 2022 May 13, 2022	BUY	$0.92 - $1.94 $95,756 - $201,921	104,083 Added 16.7%	727,265 $960,000
Q3 2021 Nov 12, 2021	BUY	$2.11 - $2.81 $47,597 - $63,387	22,558 Added 3.76%	623,182 $1.35 Million
Q2 2021 Aug 13, 2021	BUY	$2.01 - $3.0 $1.21 Million - $1.8 Million	600,624 New	600,624 $1.68 Million

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $240M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.